TMCnet News
Research and Markets: Global Contrast Induced Nephropathy Clinical Trials Review, H2, 2015Research and Markets (http://www.researchandmarkets.com/research/z3vtw4/contrast_induced) has announced the addition of the "Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015" report to their offering. Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015 provides an overview of Contrast Induced Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Contrast Induced Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical tial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. Scope
Clinical Trial Overview of Top Companies
Clinical Trial Overview of Top Institutes / Government
For more information visit http://www.researchandmarkets.com/research/z3vtw4/contrast_induced
View source version on businesswire.com: http://www.businesswire.com/news/home/20151008005542/en/ |